| Future prospects of immune checkpoint blockade in cancer: from response prediction to overcoming resistance YJ Park, DS Kuen, Y Chung Experimental & molecular medicine 50 (8), 1-13, 2018 | 202 | 2018 |
| IL-17-producing cells in tumor immunity: friends or foes? DS Kuen, BS Kim, Y Chung Immune Network 20 (1), 2020 | 87 | 2020 |
| Gα12/13 signaling in metabolic diseases YM Yang, DS Kuen, Y Chung, H Kurose, SG Kim Experimental & Molecular Medicine 52 (6), 896-910, 2020 | 33 | 2020 |
| Type 17 immunity promotes the exhaustion of CD8+ T cells in cancer BS Kim, DS Kuen, CH Koh, HD Kim, SH Chang, S Kim, YK Jeon, YJ Park, ... Journal for immunotherapy of cancer 9 (6), 2021 | 25 | 2021 |
| Autocrine TGF-β1 Maintains the Stability of Foxp3+ Regulatory T Cells via IL-12Rβ2 Downregulation G Choi, H Na, DS Kuen, BS Kim, Y Chung Biomolecules 10 (6), 819, 2020 | 15 | 2020 |
| Cavity-enhanced overtone spectroscopy of methanol in aprotic solvents: Probing solute–solvent interactions and self-associative behavior DS Kuen, KJ Feierabend The Journal of Physical Chemistry A 118 (16), 2942-2951, 2014 | 8 | 2014 |
| Critical regulation of follicular helper T cell differentiation and function by Gα13 signaling DS Kuen, M Park, H Ryu, G Choi, YH Moon, JO Kim, KW Kang, SG Kim, ... Proceedings of the National Academy of Sciences 118 (43), e2108376118, 2021 | 7 | 2021 |
| TYRO3 blockade enhances anti-PD-1 therapy response by modulating expression of CCN1 in tumor microenvironment M Park, DS Kuen, J Park, M Choi, Y Kim, EC Roh, YJ Choi, YG Kim, ... Journal for Immunotherapy of Cancer 11 (1), 2023 | 3 | 2023 |
| A personalized cancer vaccine that induces synergistic innate and adaptive immune responses DS Kuen, J Hong, S Lee, CH Koh, M Kwak, BS Kim, M Jung, YJ Kim, ... Advanced Materials 35 (36), 2303080, 2023 | 2 | 2023 |
| Alcohol-solvent interactions probed using cavity-enhanced absorption spectroscopy of OH stretching vibrational overtones DS Kuen, KJ Feierabend ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 245, 2013 | | 2013 |
